Name: Senolytics in Longevity Medicine: Dasatinib/Quercetin Trial Results | DrTalks
Uploaded: 2021-11-25T06:12:58-08:00
Description: The Role Of Senolytics In Longevity Medicine And Preliminary Results Of A Trial Of Dasatinib/Quercetin And Its Affect On DNA Methylation

Aging

Cancer

Longevity

Senolytics in Longevity Medicine: Dasatinib/Quercetin Trial Results

Telomere Summit- January 2022

<h6>Joseph M. Raffaele, M.D.</h6>
Welcome again to the Telomere Summit. This is Dr. Joseph Raffaele, your host. Today, I&#8217;m very happy to have Edwin Lee, M.D. on the program to talk about all the great work he&#8217;s been doing in his practice over the years, but in particular, a very interesting study that he&#8217;s just finished, hasn&#8217;t had all the data analysis, but we&#8217;re going to get some interim results, on the effect of senolytic combination on patients in a clinical trial. Dr. Lee is a best-selling author, international spokesperson and board-certified endocrinologist. In 2008, he founded the Institute for Hormonal Balance in Orlando, Florida, and practices functional endocrinology. 
He is a co-founder of the Clinical Peptides Society and teaches many health care providers in the use of peptides. He also formed savepeptides.org, a not-for-profit organization to save peptides from the FDA. His latest book is the &#8216;Fountain of Youth With Peptides, Discover The Regenerative Powers of Peptides&#8217;. In addition, he is finishing up a six-month senolytic study in 21 patients, as I mentioned, using Dasatinib and Quercetin, should also say that Ed is an avid triathlete and golfer and practicing what he preaches from an age management standpoint. Great to have you on the show, Ed.

https://drsummits.s3.us-west-1.amazonaws.com/2022+Summits/Telomere+Summit/Transcripts/Dr.+Edwin+Lee+Telomere+Transcript+File.pdf

Dr. Lee is a best selling author, international spokesperson and a board certified Endocrinologist. In 2008 he is the founder of the Institute for Hormonal Balance in Orlando and practices functional endocrinology. He is the co founder of Clinical Peptide Society and teaches many healthcare providers in using peptides. He is also formed SavePeptides.org a non-for-profit organization to save peptides from the FDA. His latest book is The Fountain of Youth with Peptides (Discover the regenerative powers of peptides). In addition he is finishing up a 6 month senolytic study in 21 patients using Dasatinb and Quercetin.

Edwin Lee

Dr. Raffaele received his B.A. in philosophy from Princeton University and his M.D. from Drexel University Medical School in 1989. He trained at The New York Hospital/Cornell University Medical Center and was formerly a clinical assistant professor of medicine at Dartmouth Medical School. Dr. Raffaele is board certified in internal medicine, a member of the Endocrine Society, and a diplomat of the American Board of Anti-Aging Medicine. In 1997, he co-founded PhysioAge Medical Group, where he exclusively practiced age-management medicine, focusing on personalized hormone optimization and physiological age assessment.

Senolytics in Longevity Medicine: Dasatinib/Quercetin Trial Results

Joseph Raffaele, MD

Edwin Lee

Summary

Content Provided By

Joseph Raffaele, MD

Guest Experts

Edwin Lee